Trial No.: ARMO AM0010-301 ARTIST 1
A Randomized Phase 3 Study of AM0010 in Combination with FOLFOX Compared with FOLFOX Alone as Second-Line Therapy in Patients with Metastatic Pancreatic Cancer that Have Progressed During or Following a First-Line Gemcitabine Containing Regimen
Trial No.: Halozyme HALO-109-301
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) in Combination with nab-Paclitaxel Plus Gemcitabine Compared with Placebo Plus nab-Paclitaxel and Gemcitabine in Subjects with Hyaluranan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma
©2018 Fort Wayne Medical Oncology and Hematology. All Rights Reserved.